High-Risk and Oligometastatic Prostate Cancer
1 clinical trials · Condition
◉ Watch High-Risk and Oligometastatic Prostate Cancer
| Record | Firm | Date |
|---|---|---|
| An Evaluation of the Efficacy and Safety of Apalutamide as Neoadjuvant Endocrine Therapy in High-Risk and Oligometastatic Prostate Cancer (NCT04997252) | Zhujiang Hospital | 2021-02-01 |
Track High-Risk and Oligometastatic Prostate Cancer automatically
Every clearance here is in the API, with alerts when new ones post.